Tag: cornell medical college
Brain imaging provides window into consciousness
NEW YORK (Feb. 25, 2011) -- Using a sophisticated imaging test to probe for higher-level cognitive functioning in severely brain-injured patients provides a window into consciousness -- but the view it presents is one that is blurred in fascinating ...
Trial will test whether surgery is the best option for type...
NEW YORK (Feb. 10, 2011) -- A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control d...
Sweeping view of prostate cancer genome yields deep insights
NEW YORK, CAMBRIDGE, Mass., AND BOSTON (Feb. 9, 2011) -- For the first time, researchers have laid bare the full genetic blueprint of multiple prostate tumors, uncovering alterations that have never before been detected and offering a deep view of t...
Team creates novel vaccine that produces strong immunity against cocaine high
LA JOLLA, CA -- January 4, 2011 -- Researchers from The Scripps Research Institute, Weill Cornell Medical College, and Cornell University have produced a long-lasting anti-cocaine immunity in mice by giving them a unique vaccine that combines bi...
Vaccine blocks cocaine high in mice
NEW YORK (Jan. 4, 2011) -- Researchers have produced a lasting anti-cocaine immunity in mice by giving them a safe vaccine that combines bits of the common cold virus with a particle that mimics cocaine.
In their study, published Jan. 4 ...
Coma and general anesthesia demonstrate important similarities
NEW YORK (Dec. 30, 2010) -- The brain under general anesthesia isn't "asleep" as surgery patients are often told -- it is placed into a state that is a reversible coma, according to three neuroscientists who have published an extensive review of ...
Prostate cancer’s multiple personalities revealed
NEW YORK (Nov. 3, 2010) -- Scientists at Weill Cornell Medical College have taken an important step toward a better understanding of prostate cancer by uncovering evidence that it is not one disease, as previously believed, but rather several factors...
New lymphoma therapy may be more effective with fewer side effects
NEW YORK (Nov. 3, 2010) -- Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin's lymphoma that accounts for approximately 40 percent of lymphomas among adults. If left untreated, it is fatal. The existing treatments have a c...
Hepatitis C study shows superior viral cure rate
NEW YORK (November 2, 2010) -- For patients with the most common form of hepatitis C being treated for the first time, the addition of an investigational hepatitis C -- specific protease inhibitor called telaprevir to the current standard therapy mar...
Potential new treatment for deadly nipah and hendra viruses identified by...
NEW YORK (Oct. 28, 2010) -- Scientists at Weill Cornell Medical College have identified a potential new treatment for the Nipah and Hendra viruses, two lethal and emerging viruses for which there is currently no treatment or vaccine available. The a...
